48 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) gained 82% to $25.19. The company, last month, priced its IPO at $11 per share.
Mid-Morning Market Update: Markets Mostly Higher; Wendy’s Posts Upbeat Earnings
Following the market opening Wednesday, the Dow traded up 0.54% to 35,456.02 while the NASDAQ fell 0.04% to 14,782.46. The S&P also rose, gaining 0.24% to 4,447.45.
85 Biggest Movers From Yesterday
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Achilles Therapeutics Q2 EPS $(0.45)
Achilles Therapeutics (NASDAQ:ACHL) reported quarterly losses of $(0.45) per share.
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Stocks That Hit 52-Week Lows On Thursday
During the morning session on Thursday, 152 stocks hit new 52-week lows.
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 18 companies set new 52-week lows.
The Daily Biotech Pulse: Lilly, Morphic’s Positive Data At ECCO, Humanigen’s COVID Treatment Gets Expedited Review In UK, TransCode IPO
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
The Daily Biotech Pulse: Priority Review For Amgen’s Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)